| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJO.2004.08.040 |
| P698 | PubMed publication ID | 15733983 |
| P50 | author | Kazuo Tsubota | Q11425769 |
| Takashi Kojima | Q89451015 | ||
| Murat Dogru | Q102229140 | ||
| Yukihiro Matsumoto | Q109409154 | ||
| Minako Kaido | Q114422334 | ||
| Reiko Ishida | Q114439585 | ||
| Eiki Goto | Q114439590 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 242-246 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study | |
| P478 | volume | 139 |
| Q41014437 | A Case-Control Study on the Oxidative Balance of 50% Autologous Serum Eye Drops |
| Q90615647 | A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain |
| Q92442286 | Advances in dry eye disease treatment |
| Q54977470 | Application of Novel Drugs for Corneal Cell Regeneration. |
| Q31096052 | Application of umbilical cord serum eyedrops after laser epithelial keratomileusis |
| Q36764408 | Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions |
| Q24200233 | Autologous serum eye drops for dry eye |
| Q24234791 | Autologous serum eye drops for dry eye syndrome |
| Q30235522 | Autologous serum eye drops for dry eye. |
| Q37137885 | Autologous serum eyedrops: literature review and implications for transfusion medicine specialists |
| Q36673998 | Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel. |
| Q36138820 | Bioengineered Lacrimal Gland Organ Regeneration in Vivo |
| Q38636912 | Blood derived eye drops for the treatment of cornea and ocular surface diseases |
| Q90164048 | Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus |
| Q38547921 | Blood-derived topical therapy for ocular surface diseases |
| Q44412563 | Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study |
| Q47336283 | Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy. |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q46857139 | Current treatment for dry eye syndrome |
| Q80347916 | Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007) |
| Q39352252 | Diagnostic procedures and management of dry eye. |
| Q39404635 | Dry Eye Management: Targeting the Ocular Surface Microenvironment. |
| Q46025632 | Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. |
| Q38102006 | Emerging drugs for the treatment of dry eye disease |
| Q43122185 | Epithelial healing in experimental corneal alkali wounds with nondiluted autologous serum eye drops. |
| Q30432843 | Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. |
| Q35805082 | Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED). |
| Q52722912 | Feline dry eye syndrome of presumed neurogenic origin: a case report. |
| Q36929473 | Graft failure: II. Ocular surface complications |
| Q47975849 | Human Breast Milk Drops Promote Corneal Epithelial Wound Healing |
| Q26778628 | Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis |
| Q33731372 | Identification of transcription factors that promote the differentiation of human pluripotent stem cells into lacrimal gland epithelium-like cells |
| Q37940581 | Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment |
| Q35223432 | Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. |
| Q80347919 | Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) |
| Q34028408 | Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. |
| Q38442433 | Manufacture of autologous serum eye drops for out-patient therapy : cooperation between ophthalmic clinic and transfusion medicine department |
| Q36766324 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report |
| Q43075719 | Neuropathic Corneal Pain: Approaches for Management |
| Q47739620 | Neuropathic pain and dry eye. |
| Q38058002 | New agents for treating dry eye syndrome. |
| Q47239843 | Noninvasive Electrical Stimulation for the Treatment of Chronic Ocular Pain and Photophobia. |
| Q81551290 | Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease |
| Q52889021 | Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model. |
| Q37826752 | Pharmacotherapy of dry eye. |
| Q38723772 | Quality standards, safety and efficacy of blood-derived serum eye drops: A review |
| Q55056224 | Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q79755734 | Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation |
| Q38887004 | Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease |
| Q36718011 | Science and strategy for preventing and managing corneal ulceration. |
| Q47203561 | Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome |
| Q38540177 | Serum eye drop preparation in Australia: Current manufacturing practice |
| Q93073551 | Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis |
| Q38884551 | Serum eye drops: a survey of international production methods. |
| Q91999712 | Serum growth factor stability in different eye drop packaging systems during storage |
| Q83682081 | Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion |
| Q35699085 | Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops |
| Q35570793 | Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture |
| Q36864045 | The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study |
| Q49925651 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. |
| Q39211271 | The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study |
| Q39206326 | The lacrimal gland: development, wound repair and regeneration |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q35978885 | The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center |
| Q26822610 | Therapeutic Strategies to Treat Dry Eye in an Aging Population |
| Q42041153 | Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery |
| Q36056942 | Treating Sjögren's Syndrome: Insights for the Clinician |
| Q42729437 | Treating ocular surface disease: new agents in development |
| Q48262564 | Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sjögren syndrome |
| Q30421187 | Use of umbilical cord serum in ophthalmology |
| Q42499311 | Using corneal confocal microscopy to track changes in the corneal layers of dry eye patients after autologous serum treatment. |
| Q82253234 | [Ophthalmological complications in Sjögren's syndrome] |
| Q81671351 | [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy] |
Search more.